PAPER Singh SP, Gupta S, Rajapakse JC
SEARCH RESULTS
331061 RESULTS
PAPER Lacey C, Paterson T, Gawryluk JR, Alzheimer’s Disease Neuroimaging Initiative
Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
PLoS One. 2024;19(4):e0292576. Epub 2024 Apr 18 PubMed: 38635499PAPER Schlein E, Andersson KG, Dallas T, Syvänen S, Sehlin D
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody.
MAbs. 2024;16(1):2339337. Epub 2024 Apr 18 PubMed: 38634473PAPER Khalil B, Da Cruz S
14-3-3θ, a novel player in TDP-43 pathophysiology: Implications for ALS/FTD.
Neuron. 2024 Apr 17;112(8):1197-1199. PubMed: 38636451PAPER Huang Z, He G, Sun S, Huang Y
Causal relationship of genetically predicted particulate matter 2.5 level with Alzheimer's disease and the mediating effect of dehydroepiandrosterone sulphate.
Ann Hum Biol. 2024 Feb;51(1):2337731. Epub 2024 Apr 18 PubMed: 38634600PAPER Petit P, Gondard E, Gandon G, Moreaud O, Sauvée M, Bonneterre V
Correction: Agricultural activities and risk of Alzheimer's disease: the TRACTOR project, a nationwide retrospective cohort study.
Eur J Epidemiol. 2024 Apr 18; PubMed: 38637461PAPER Park JE, Chaudhary CL, Bhattarai D, Kim KB
Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer's Disease.
J Med Chem. 2024 Apr 18; PubMed: 38636481PAPER Limberger C, Zimmer ER
Blood GFAP reflects astrocyte reactivity to Alzheimer's pathology in post-mortem brain tissue.
Brain. 2024 Apr 18; PubMed: 38634672PAPER Andrade SM, de Oliveira Marques CC, de Lucena LC, Vieira da Costa K, de Souza IC, da Silva Machado CB, Queiroz ME, Costa LP, Silva ST
Effect of transcranial direct current stimulation and transcranial magnetic stimulation on the cognitive function of individuals with Alzheimer's disease: a systematic review with meta-analysis and meta-regression.
Neurol Res. 2024 Apr 18;:1-13. PubMed: 38634361Jess Smith
Australia
PAPER Salmon E, Lekeu F, Quittre A, Godichard V, Olivier C, Wojtasik V, Bastin C
Awareness and cognitive rehabilitation in Alzheimer's disease and frontotemporal dementia.
Alzheimers Dement (N Y). 2024;10(2):e12469. Epub 2024 Apr 16 PubMed: 38633527PAPER Akkaya D, Seyhan G, Sari S, Barut B
In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease.
Drug Dev Res. 2024 May;85(3):e22184. PubMed: 38634273PAPER Imtiaz A, Shimonaka S, Uddin MN, Elahi M, Ishiguro K, Hasegawa M, Hattori N, Motoi Y
Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates.
Front Aging Neurosci. 2024;16:1368291. Epub 2024 Mar 26 PubMed: 38633982PAPER Rinaldi M, Pezone A, Quadrini GI, Abbadessa G, Laezza MP, Passaro ML, Porcellini A, Costagliola C
Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies.
Front Aging Neurosci. 2024;16:1371745. Epub 2024 Apr 3 PubMed: 38633983PAPER Castellanos Otero P, Todd TW, Shao W, Jones CJ, Huang K, Daughrity LM, Yue M, Sheth U, Gendron TF, Prudencio M, Oskarsson B, Dickson DW, Petrucelli L, Zhang YJ
Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
PLoS One. 2024;19(4):e0298080. Epub 2024 Apr 18 PubMed: 38635657Current Filters
No filters selected